Nicholas Wilcken

Associate Professor Nicholas Wilcken is an academic clinician at the University of Sydney's NHMRC Clinical Trials Centre and Central Clinical School. He serves as Director of Medical Oncology at Westmead Hospital and Senior Staff Specialist at Nepean Hospital. His roles include Chair of the SAC for the ANZ Breast Cancer Trials Group and Coordinating Editor of the Cochrane Collaboration Breast Cancer Group.

He completed medical studies at UNSW, general medical training at Prince of Wales Hospital, oncology training at Royal Prince Alfred Hospital, and a PhD at the Garvan Institute. His research focuses on breast cancer treatment, clinical trials methodology, and evidence-based guidelines.

Wilcken's research interests span breast cancer therapy optimization, systematic reviews, and clinical trial design. His work emphasizes translating evidence into clinical practice, particularly for metastatic and HER2-positive breast cancers. Recent publications include studies on genomic profiling for cancer diagnosis, immunotherapy biomarkers, and treatment decision-making in ER-positive breast cancer.

His contributions to oncology include leadership in collaborative breast cancer trials and methodological advancements in systematic reviews. He has authored over 100 peer-reviewed articles across journals like Journal of Clinical Oncology and Cochrane Database of Systematic Reviews.

Wilcken actively participates in clinical care and academic leadership, bridging research and practice in oncology.